Recombinant Human VEGFA/VEGF165 Protein, C-His
Overview
Catalog No.
HB941011
Form
Lyophilized
Storage buffer
Lyophilized from a solution in PBS pH 7.4, 1 mM EDTA, 4% Trehalose, 1% Mannitol.
Purity
>90% as determined by SDS-PAGE.
Applications
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Endotoxin level
Please contact with the lab for this information.
Expression system
Mammalian Cells
Accession
P15692-4
Protein length
Met1-Arg191
Nature
Recombinant
Predicted molecular weight
23.28 kDa
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Reconstitution
Reconstitute in sterile water for a stock solution.
Alternative name
Vascular endothelial growth factor A, VPF, VEGFA, VEGF, Vascular permeability factor, VEGF-A
Species
Homo sapiens (Human)
Shipping
In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Note
For research use only.
Images
SDS-PAGE
SDS-PAGE for Recombinant Human VEGFA/VEGF165 Protein, C-His
Bioactivity
Detects VEGFA in indirect ELISAs.
Bioactivity
Detects BD0801 in indirect ELISAs.
Bioactivity
Detects Dilpacimab in indirect ELISAs.
Bioactivity
Detects Conbercept in indirect ELISAs.
Bioactivity
Detects Human VEGFA Antibody in indirect ELISAs.
Bioactivity
Detects Vanucizumab in indirect ELISAs.
Bioactivity
Detected by Research Grade Ivonescimab in indirect ELISA.
Bioactivity
Detected by Research Grade Faricimab (Cat No.: HT073016) in indirect ELISA.